The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for Seegene’s Allplex 2019-nCoV Assay for Covid-19.
Allplex is a real-time RT-PCR test for SARS-CoV-2, the novel coronavirus which causes the disease. It is being used as a standard SARS-CoV-2 assay and can identify E, RdRP and N target genes in a single reaction tube.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The authorisation is expected to enable US laboratories to run the Seegene’s test immediately for high-volume testing.
